Author

H. Dowst

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:database / resource· 1 Assay:DNA methylation· 1

Frequent Co-Authors

L. E. Dobrolecki· 2 shared M. T. Lewis· 2 shared S. G. Hilsenbeck· 2 shared A. B. Saltzman· 1 shared A. F. Espinoza· 1 shared A. Hernandez-Herrera· 1 shared A. Malovannaya· 1 shared A. McOwiti· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. E. Dobrolecki

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BCM PDX Portal: An Intuitive Web-based Tool for Patient-Derived Xenograft Collection Management, as well as Visual Integration of Clinical and Omics Data

H. Dowst, A. McOwiti, F. Zheng, R. Rajaram Srinivasan, A. Hernandez-Herrera, N. Rainusso, L. Brubaker, Q. C. Yao, M. Redell, A. Stevens, S. Lerner, S. Woodfield, A. F. Espinoza, J. D. Landua, S. G. Hilsenbeck, , M. T. Lewis

The BCM PDX Portal manages PDX collections and integrates clinical and omics data for drug evaluation.

bioRxiv · Feb 15, 2023 · PreprintCancer Biology

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

V. Petrosyan, L. E. Dobrolecki, L. Thistlethwaite, A. N. Lewis, C. Sallas, R. Rajaram, J. T. Lei, M. J. Ellis, K. Osborne, M. Rimawi, A. Pavlick, M. Shafaee, H. Dowst, A. B. Saltzman, A. Malovannaya, , M. T. Lewis

This paper identifies biomarkers of differential chemotherapy response in TNBC using a network-based approach and validates them in PDX models and clinical datasets.

bioRxiv · Aug 20, 2021 · PreprintCancer Biology